×
This post has expired! It was posted more than 90 days ago.
<- Back

85771 - Hepatitis C New Treatments Course

  • : Online

 

The course will be delivered in two parts: 
Part 1 consists of an eLearning component of approximately 2 hours’ duration. It comprises 5 separate modules which introduce topics related 
to the assessment, management and treatment of hepatitis C. 
Part 2 consists of an interactive face-to-face workshop of 5 hours’ duration that builds on the knowledge and skills gained in the Part 1 eLearning through case discussions facilitated by experts in the field of hepatitis C treatment.

Relevance to General Practice

This comprehensive course aims to increase participants’ knowledge, skills and confidence when prescribing the new direct acting antivirals (DAAs) in accordance with the PBS requirements or advising patients about the new therapies.

Learning outcomes
  • Screen at risk patients, order and interpret tests appropriately to diagnose chronic hepatitis C infection
  • Perform the recommended baseline assessment including assessing liver disease severity and screening for potential drug-drug interactions, manage comorbidities
  • Explain approved antiviral treatment options and duration of therapy for all HCV genotypes based on prior treatment experience and cirrhotic status
  • Prescribe HCV antiviral therapy in accordance with PBS patient and prescriber eligibility criteria
  • Recognise risk factors, clinical signs, symptoms and complications of advanced liver disease and manage or refer to specialist care appropriately
  • Delivery
    Title
    85771 - Hepatitis C New Treatments Course
    Location
    Duration
    6.5 hours
    Start Date
    10-Aug-2019
    End Date
    31-Dec-2019
    CPD Points
    6.5 hours
    Price
    Free
    Location
    Online
    Contact Phone
    Log in into view this field.
    HealthcareLink